Atlas Trials

Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents

Clinical trial NCT05372783 · WITHDRAWN

Trial details

NCT number
NCT05372783
Sponsor
Sorrento Therapeutics, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2023-04-01
Primary completion
2024-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.